Supplementary Figure 1 Fatty acid oxidation is emphasized in 1 macrophages compared with that in macrophages. Gene expression of mitochondrial OXPHOS (Atp5j, Cox4i1, Uqcrc1/2, Ndufs1, Sdhb) and β-oxidation (Acadm, Acox1, Crot, CPT2, Acadl, Crat) pathways in and macrophages. (b) Relative expression in vs. macrophages of key activation indicator genes used for the analysis in a. (c) Expression levels of genes used in this study (GSE5353). Data shown are from two independent RNA-Seq analyses. Nature Immunology: doi:1.138/ni.2956
Supplementary Figure 2 macrophages survive longer than or macrophages do. Cell survival, measured by lack of staining with 7-AAD, in cultured macrophages over time. Tissue culture medium and activation signals (IL-4 for, IFN-γ and LPS for ) were replaced every 2 days. Data points are mean values + SEM for 3 replicate conditions per time point from 1 experiment representative of 2. Nature Immunology: doi:1.138/ni.2956
a b + orlistat Pnpla2 +/+ + PBS Pnpla2 +/+ + IL-4c Pnpla2 -/- + IL-4c 92.5 ± 3.5% 91.7 ± 3.8% 1 2 1 3 1 4 1 5 RELMα c + Lipa shrna 5 nm US + orlistat + CLQ 1 2 1 3 1 4 1 5 1 2 1 3 1 4 1 5 BODIPY 493/53 2 µm d TG(16:,16:,18:1) TG(16:,18:1,18:1) CE16: CE16:1.25.5.8.5.2.15.1.5. + orlistat.4.3.2.1. + orlistat.6.4.2. + orlistat.4.3.2.1. + orlistat TG(18:1,18:,18:) TG(18:1,18:1,18:) CE18:1 CE18:2.15.15.8.25.1.5. + orlistat.1.5. + orlistat.6.4.2. + orlistat.2.15.1.5. + orlistat Nature Immunology: doi:1.138/ni.2956
Supplementary Figure 3 Lack of ATGL does not affect activation in vivo, and lipid droplets accumulate in macrophages when lipolysis is inhibited. (a) activation in peritoneal macrophages from wild-type (Pnpla2 +/+ ) and Pnpla2 -/- mice injected with PBS (wild-type only) or IL-4c was measured by RELMα expression using flow cytometry. Numbers indicate mean ± SEM values for % macrophages positive for RELM in 3 technical replicates per condition. Data are from peritoneal macrophages pooled from 2 mice per group from 1 experiment representative of 3. (b) Representative electron micrographs of macrophages cultured in IL-4 in the presence of orlistat for 24 h ( + orlistat) and of Lipa shrna-transduced macrophages cultured in IL-4 for 24 h ( + Lipa shrna); These images from 1 experiment representative of 2. c) Neutral lipid accumulation in macrophages cultured in complete medium in the absence or presence of orlistat or chloroquine (CLQ). Neutral lipids were detected by BODIPY staining followed by flow cytometry. Fluorescence staining was compared to unstained cells (US), cells, and to cells cultured without orlistat or CLQ. Data are from 1 experiment representative of 2. (d) Mass spectrometric quantitation of different triacylglycerol (TG) and cholesterol ester (CE) species in.,, and orlistat treated macrophages. Ratios reflect fatty acid chain length to double bonds for the species detected in TGs, or for CEs. In d, data are mean ± SEM values from 2 replicate samples from one experiment. Numbers above graph bars show actual mean values per condition. Nature Immunology: doi:1.138/ni.2956
a US Cd36 + + Cd36 BODIPY-Palmitate (gmfi) 6 1 3 5 1 3 4 1 3 3 1 3 2 1 3 1 1 3 Cd36 + + Cd36 b US + SSO 1 2 1 3 1 4 1 5 BODIPY-Palmitate 1 2 1 3 1 4 1 5 BODIPY-LDL c OCR (pmol/min) 2 15 1 5 *** OCR/ECAR (pmol/mph) 8 *** 6 4 2 + SSO SRC (%) 15 1 5 ** + SSO d OCR (pmol/min) 12 9 6 3 OCR/ECAR (pmol/mph) 6 5 4 3 2 1 + SSO e f CD31 PD-L2 + SSO 1 5 1.5 ±.4 29.4 ± 5. 5.3 ±.1 1 4 1 3 1 2 1 2 1 3 1 4 1 5 CD26 1 5 1.1 ±.1 45.7 ± 3.6 19.9 ± 4.4 1 4 1 3 1 2 1 2 1 3 1 4 1 5 RELMα 1 2 1 3 1 4 1 5 inos + SSO 62.8 ± 11.7% 64.4 ± 8.4% Supplementary Figure 4 CD36 is not required for increased palmitate uptake by macrophages but is important for LDL uptake and activation. (a) BODIPY-palmitate uptake by WT and Cd36 -/- and macrophages, as measured by flow cytometry. (b-g) The effect of the CD36 inhibitor sulfo-n-succinimidyl oleate (SSO) on (b) the uptake of LDL by macrophages, (c) basal OCR, the ratio of basal OCR to basal ECAR, and SRC in macrophages, (d) basal OCR and the ratio of basal OCR to basal ECAR in macrophages, (e) CD26 and CD31 expression and PD-L2 and RELMα expression by macrophages, (f) inos expression by macrophages. In b-g macrophages were pre-treated with SSO for 3 minutes prior to the addition of polarizing stimuli, and data were collected 24 h later. Data in b-g from macrophages are shown for comparison. Data in the histograms in a and b are from 1 experiment representative of 2. Data in the bar graph in a are means ± SEM of data from 2 independent experiments. Data in c and d are means ± SEM of 3 technical replicates from one experiment representative of 3. Numbers in e refer to the percentages of macrophages that fall within the indicated gates. Plots are from one representative experiment, numbers are means ± SEM of data from 3 independent experiments. In f, histograms showing expression of inos are from one experiment representative of 2, numbers are means ± SEM from 2 independent experiments of % of cells expressing inos. P values are from Student s t-test (*P <.1; **P < Nature Immunology: doi:1.138/ni.2956
.1). Nature Immunology: doi:1.138/ni.2956
a PD-L2 + Serum + 5-L/V + 5-L/V Serum 1 5 1.4 ±.1 3.9 ± 1.4 27.9 ± 1.4 17.4 ± 3.1 14.3 ±.9 1 4 1 3 1 2 1 2 1 3 1 4 1 5 RELMα b 1.2 ±.2 + orlistat + TOFA + orlistat + TOFA 37.3 ± 7. 18.7 ± 5.3 21.8 ± 9.4 13.3 ± 6.2 + Serum Serum PD-L2 1 5 1 4 1 3 1.3 ±.3 16.1 ± 8.5 7.1 ± 2.1.1 ±.3.3 ±.1 1 2 1 2 1 3 1 4 1 5 RELMα Supplementary Figure 5 activation can occur in serum-free conditions but is increased by the addition of serum or LDL and VLDL. (a) Macrophages were cultured with IL-4 () for 24 h in medium containing (+Serum) or lacking serum (-Serum), or in serum free medium with added 5 or 5 μg/ml of LDL/VLDL (5-L/V or 5-L/V). PD-L2 and RELMα expression were measured by flow cytometry, (b) Macrophages were cultured with IL-4 for 24 h in the absence () or presence of inhibitors of lipolysis (orlistat) or fatty acid synthesis (TOFA), in medium containing (+Serum) or lacking (-Serum) serum. In both a and b, cells destined to be tested in serum-free medium were pre-cultured under these conditions for 24 h prior to the addition of IL-4. Numbers refer to the percentages of macrophages that fall within the indicated gates. Plots are from one experiment representative of 2, numbers are means ± SEM of data from 2 independent experiments. Nature Immunology: doi:1.138/ni.2956
a b total cells (x1 7 ) 12 1 8 6 4 NS NS Naive 1 Hp 1 Hp + orlistat 2 Hp 2 Hp + orlistat hucd2 1 5 1 4 1 3 1 2 Naïve.3 1 Hp 12 1 Hp + orlistat 1 2 1 2 1 3 1 4 1 5 GFP 2 Hp 2 Hp + orlistat 1 5 1 4 1 3 1 1 hucd2 1 2 1 2 1 3 1 4 1 5 GFP Supplementary Figure 6 Inhibition of lipolysis does not prevent IL-4 production by T H 2 cells during H. polygyrus infection. 4get/KN2 IL-4 reporter mice were infected with H. polygyrus and treated with the anti-helminthic pyrantel pamoate prior to receiving a secondary infection (2ºHp). At the time of secondary infection, additional groups of mice were infected for the first time to provide primary H. polygyrus infection controls (1ºHp). Infected mice were treated with Orlistat, or remained untreated, as indicated. At day 9 post infection, mice were sacrificed and mesenteric lymph nodes were removed. (a) Cellularity of mesenteric lymph nodes in naïve 4get/KN2 mice and in infected mice mice treated variously as shown. (b) IL-4 production, as measured by flow cytometric analysis of expression of hucd2 and GFP immediately ex vivo, in gated CD4 + T cells from mesenteric lymph nodes of 4get/KN2 mice under the conditions shown (see Fig. 7 legend for more details). In these plots, GPF expression reflects transcription of the Il4 gene, and hucd2 expression reflects IL-4 protein production. Data in a represent mean values ± SEM from 3 or more individually assessed mice from 1 experiment representative of 2. Data in b are from lymph nodes pooled from 3 or more mice per group from 1 experiment representative of 2. Numbers in b represent percentages of CD4 + T cells falling within indicated gates. NS = not significant according to Student s t-test. Nature Immunology: doi:1.138/ni.2956